HELX · Franklin Genomic Advancements ETF ETF
Franklin Templeton ETF Trust
$41.89
-1.00%
At close · Sep 4
Net assets $27,936,547
Holdings63
1 month
+1.35%
Year to date
+15.38%
52-week range
$29.80–$43.51
30-session avg volume
2,476
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000067393
- Report date
- Jun 30, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings47.05%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC97.88%
EP0.85%
Country allocation
US86.61%
GB3.04%
KR2.63%
DE2.23%
NL2.12%
CH1.21%
IE0.78%
SG0.10%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| GUARDANT HEALTH INC | GH | $2,539,558 | 9.09% |
| NATERA INC | NTRA | $2,084,465 | 7.46% |
| KRYSTAL BIOTECH INC | KRYS | $1,768,034 | 6.33% |
| LIGAND PHARMACEUTICALS INC | LGND | $1,291,228 | 4.62% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | $1,114,456 | 3.99% |
| UNITED THERAPEUTICS CORP | UTHR | $980,170 | 3.51% |
| BRIDGEBIO PHARMA INC | BBIO | $977,848 | 3.50% |
| ELI LILLY & COMPANY | LLY | $825,208 | 2.95% |
| TWIST BIOSCIENCE CORP | TWST | $795,880 | 2.85% |
| VERTEX PHARMACEUTICALS INC | VRTX | $767,448 | 2.75% |
| ASTRAZENECA PLC | 000000000 | $754,498 | 2.70% |
| TRAVERE THERAPEUTICS INC | TVTX | $724,498 | 2.59% |
| INSMED INC | INSM | $681,089 | 2.44% |
| SAMSUNG BIOLOGICS CO LTD | 000000000 | $630,273 | 2.26% |
| CORTEVA INC | CTVA | $629,670 | 2.25% |
| MEDPACE HOLDINGS INC | MEDP | $600,025 | 2.15% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | $546,670 | 1.96% |
| TEMPUS AI INC | TEM | $544,368 | 1.95% |
| IONIS PHARMACEUTICALS INC | IONS | $534,335 | 1.91% |
| NEUROCRINE BIOSCIENCES INC | NBIX | $515,380 | 1.84% |
| REGENERON PHARMACEUTICALS INC | REGN | $501,950 | 1.80% |
| VERACYTE INC | VCYT | $459,210 | 1.64% |
| ARGENX SE | 000000000 | $458,271 | 1.64% |
| PTC THERAPEUTICS INC | PTCT | $408,584 | 1.46% |
| BIONTECH SE | BNTX | $386,716 | 1.38% |
| STOKE THERAPEUTICS INC | STOK | $371,339 | 1.33% |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | CRL | $352,885 | 1.26% |
| GRAIL INC | GRAL | $304,211 | 1.09% |
| ANAPTYSBIO INC | ANAB | $289,575 | 1.04% |
| CRISPR THERAPEUTICS AG | 000000000 | $274,336 | 0.98% |
| REPLIGEN CORP | RGEN | $274,108 | 0.98% |
| CADENCE DESIGN SYSTEMS INC | CDNS | $272,107 | 0.97% |
| BEAM THERAPEUTICS INC | BEAM | $260,043 | 0.93% |
| PRAXIS PRECISION MEDICINES INC | PRAX | $240,379 | 0.86% |
| SARTORIUS AG | 000000000 | $237,564 | 0.85% |
| AXSOME THERAPEUTICS INC | AXSM | $229,105 | 0.82% |
| CAREDX INC | CDNA | $228,000 | 0.82% |
| JAZZ PHARMACEUTICALS PLC | 000000000 | $218,078 | 0.78% |
| CATALYST PHARMACEUTICALS INC | 14888U101 | $215,767 | 0.77% |
| THERMO FISHER SCIENTIFIC INC | TMO | $211,073 | 0.76% |
| IQVIA HOLDINGS INC | IQV | $209,064 | 0.75% |
| HINGE HEALTH INC | HNGE | $194,967 | 0.70% |
| ULTRAGENYX PHARMACEUTICAL INC | RARE | $171,324 | 0.61% |
| AGILENT TECHNOLOGIES INC | A | $162,451 | 0.58% |
| DANAHER CORP | DHR | $160,384 | 0.57% |
| QIAGEN NV | 000000000 | $133,683 | 0.48% |
| RHYTHM PHARMACEUTICALS INC | RYTM | $116,359 | 0.42% |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | $115,945 | 0.42% |
| SAMSUNG EPIS HOLDINGS CO LTD | 000000000 | $104,357 | 0.37% |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 000000000 | $94,582 | 0.34% |